The Ayurveda drug industry is growing at an estimated 15% in India and Maharashtra state Rs 16-crore Ayurved Cluster in Maharashtra by the Central Government.
The public-private partnership (PPP), project to come up in Pune, envisages a modern drug laboratory to ensure quality control of Ayurvedic products in addition to facilities for raw material processing, packing and labeling of the drugs.
Maharashtra and Kerala have been selected by the Centre's Ayush Department (alternative medicine), under the Health Ministry, as the two states are leading in propagation and practice of the age old Ayurveda that is finding global acceptance, coordinator of the proposed venture, in which 60 % of the project cost would be borne by the Union Government.
Forty percent of the capital investment is expected to come from private partners. The Maharashtra Ayush Cluster, as christened by the promoters, will be participating in the scheme by Bharati Kisan Sangh (BKS), which will ask its member farmers to go in for Ayurveda medicinal plant cultivation for the processing to be done at the cluster.